These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 39031199)

  • 1. The role of clonal progression leading to the development of therapy-related myeloid neoplasms.
    Guarnera L; Pascale MR; Hajrullaj H; Cristiano A; Mallegni F; Onorato A; Voso MT; Fabiani E
    Ann Hematol; 2024 Sep; 103(9):3507-3517. PubMed ID: 39031199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of clonal hematopoiesis as driver of therapy-related myeloid neoplasms after autologous stem cell transplantation.
    Gramegna D; Bertoli D; Cattaneo C; Almici C; Re A; Belotti A; Borlenghi E; Lanzi G; Archetti S; Verardi R; Brugnoni D; Sciumè M; Daffini R; Roccaro AM; Tucci A; Rossi G
    Ann Hematol; 2022 Jun; 101(6):1227-1237. PubMed ID: 35380239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutational patterns and their correlation to CHIP-related mutations and age in hematological malignancies.
    Stengel A; Baer C; Walter W; Meggendorfer M; Kern W; Haferlach T; Haferlach C
    Blood Adv; 2021 Nov; 5(21):4426-4434. PubMed ID: 34570179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonal haemopoiesis and therapy-related myeloid malignancies in elderly patients: a proof-of-concept, case-control study.
    Gillis NK; Ball M; Zhang Q; Ma Z; Zhao Y; Yoder SJ; Balasis ME; Mesa TE; Sallman DA; Lancet JE; Komrokji RS; List AF; McLeod HL; Alsina M; Baz R; Shain KH; Rollison DE; Padron E
    Lancet Oncol; 2017 Jan; 18(1):112-121. PubMed ID: 27927582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Next-generation sequencing of acute myeloid leukemia identifies the significance of TP53, U2AF1, ASXL1, and TET2 mutations.
    Ohgami RS; Ma L; Merker JD; Gotlib JR; Schrijver I; Zehnder JL; Arber DA
    Mod Pathol; 2015 May; 28(5):706-14. PubMed ID: 25412851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene mutation analysis using next-generation sequencing and its clinical significance in patients with myeloid neoplasm: A multi-center study from China.
    Li J; Pei L; Liang S; Xu S; Wang Y; Wang X; Liao Y; Zhan Q; Cheng W; Yang Z; Tang X; Zhang H; Xiao Q; Chen J; Liu L; Wang L
    Cancer Med; 2023 Apr; 12(8):9332-9350. PubMed ID: 36799265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy-related clonal cytopenia as a precursor to therapy-related myeloid neoplasms.
    Shah MV; Mangaonkar AA; Begna KH; Alkhateeb HB; Greipp P; Nanaa A; Elliott MA; Hogan WJ; Litzow MR; McCullough K; Tefferi A; Gangat N; Patnaik MM; Al-Kali A; He R; Chen D
    Blood Cancer J; 2022 Jul; 12(7):106. PubMed ID: 35803921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonal Hematopoiesis of Indeterminate Potential Predicts Adverse Outcomes in Patients With Atherosclerotic Cardiovascular Disease.
    Gumuser ED; Schuermans A; Cho SMJ; Sporn ZA; Uddin MM; Paruchuri K; Nakao T; Yu Z; Haidermota S; Hornsby W; Weeks LD; Niroula A; Jaiswal S; Libby P; Ebert BL; Bick AG; Natarajan P; Honigberg MC
    J Am Coll Cardiol; 2023 May; 81(20):1996-2009. PubMed ID: 37197843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular Disease Among Patients With AML and CHIP-Related Mutations.
    Calvillo-Argüelles O; Schoffel A; Capo-Chichi JM; Abdel-Qadir H; Schuh A; Carrillo-Estrada M; Liu S; Gupta V; Schimmer AD; Yee K; Shlush LI; Natarajan P; Thavendiranathan P
    JACC CardioOncol; 2022 Mar; 4(1):38-49. PubMed ID: 35492819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonal Hematopoiesis and Therapy-Related Myeloid Neoplasms After Autologous Transplant for Hodgkin Lymphoma.
    Yan C; Richard MA; Gibson CJ; He J; Bosworth A; Crossman DK; Singh P; Hageman L; Kalra R; Armenian SH; Vose J; Weisdorf DJ; Ebert BL; Yasui Y; Forman SJ; Bhatia R; Bhatia S
    J Clin Oncol; 2024 Jul; 42(20):2415-2424. PubMed ID: 38635938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of risk for myeloid malignancy in clonal hematopoiesis.
    Weeks LD; Niroula A; Neuberg D; Wong W; Lindsley RC; Luskin M; Berliner N; Stone RM; DeAngelo DJ; Soiffer R; Uddin MM; Griffin G; Vlasschaert C; Gibson CJ; Jaiswal S; Bick AG; Malcovati L; Natarajan P; Ebert BL
    NEJM Evid; 2023 May; 2(5):. PubMed ID: 37483562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CHIP-associated mutant ASXL1 in blood cells promotes solid tumor progression.
    Liu X; Sato N; Shimosato Y; Wang TW; Denda T; Chang YH; Yabushita T; Fujino T; Asada S; Tanaka Y; Fukuyama T; Enomoto Y; Ota Y; Sakamoto T; Kitamura T; Goyama S
    Cancer Sci; 2022 Apr; 113(4):1182-1194. PubMed ID: 35133065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preexisting TP53-Variant Clonal Hematopoiesis and Risk of Secondary Myeloid Neoplasms in Patients With High-grade Ovarian Cancer Treated With Rucaparib.
    Kwan TT; Oza AM; Tinker AV; Ray-Coquard I; Oaknin A; Aghajanian C; Lorusso D; Colombo N; Dean A; Weberpals J; Severson E; Vo LT; Goble S; Maloney L; Harding T; Kaufmann SH; Ledermann JA; Coleman RL; McNeish IA; Lin KK; Swisher EM
    JAMA Oncol; 2021 Dec; 7(12):1772-1781. PubMed ID: 34647981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of p53 in regulation of hematopoiesis in health and disease.
    Barajas S; Cai W; Liu Y
    Curr Opin Hematol; 2022 Jul; 29(4):194-200. PubMed ID: 35787548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical, Mutational, and Transcriptomic Characteristics in Elderly Korean Individuals With Clonal Hematopoiesis Driver Mutations.
    Moon I; Kong MG; Ji YS; Kim SH; Park SK; Suh J; Jang MA
    Ann Lab Med; 2023 Mar; 43(2):145-152. PubMed ID: 36281508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathologic Features of Therapy-Related Myeloid Neoplasms in Patients with Myeloma in the Era of Novel Therapies.
    Jelloul FZ; Quesada AE; Yang RK; Li S; Wang W; Xu J; Tang G; Yin CC; Fang H; El Hussein S; Khoury J; Bassett RL; Garcia-Manero G; Manasanch EE; Orlowski RZ; Qazilbash MH; Patel KP; Medeiros LJ; Lin P
    Mod Pathol; 2023 Jun; 36(6):100166. PubMed ID: 36990279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of the variant allele frequency of ASXL1, DNMT3A, JAK2, TET2, TP53, and NPM1 on the outcomes of patients with newly diagnosed acute myeloid leukemia.
    Sasaki K; Kanagal-Shamanna R; Montalban-Bravo G; Assi R; Jabbour E; Ravandi F; Kadia T; Pierce S; Takahashi K; Nogueras Gonzalez G; Patel K; Soltysiak KA; Cortes J; Kantarjian HM; Garcia-Manero G
    Cancer; 2020 Feb; 126(4):765-774. PubMed ID: 31742675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonal hematopoiesis of indeterminate potential (CHIP) and cardiovascular diseases-an updated systematic review.
    Senguttuvan NB; Subramanian V; Venkatesan V; Muralidharan TR; Sankaranarayanan K
    J Genet Eng Biotechnol; 2021 Jul; 19(1):105. PubMed ID: 34279740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer patients with clonal hematopoiesis die from primary malignancy or comorbidities despite higher rates of transformation to myeloid neoplasms.
    Chien KS; Ong F; Kim K; Li Z; Kanagal-Shamanna R; DiNardo CD; Takahashi K; Montalban-Bravo G; Hammond D; Sasaki K; Pierce SA; Kantarjian HM; Garcia-Manero G
    Cancer Med; 2024 Mar; 13(5):e7093. PubMed ID: 38497538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clonal hematopoiesis of indeterminate potential-associated mutations and risk of comorbidities in patients with myelodysplastic syndrome.
    Naqvi K; Sasaki K; Montalban-Bravo G; Alfonso Pierola A; Yilmaz M; Short N; Assi R; Jabbour E; Ravandi F; Kadia T; Pierce S; Takahashi K; Nogueras Gonzalez G; Kanagal-Shamanna R; Patel K; Soltysiak KA; Kantarjian HM; Garcia-Manero G
    Cancer; 2019 Jul; 125(13):2233-2241. PubMed ID: 30861111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.